title: [Imaging and PET-CT of adult and childhood lymphoma].
abstract: Malignant lymphomas are lymphoproliferative disorders arising in both lymphoid tissue and non-lymphoid organ systems. Treatment rarely is surgical, and currently relies on a combination of chemotherapy and radiation therapy. The role of imaging is to determine the spread of the disease, to identify targets and to assess therapeutic response. Imaging techniques mainly use morphological criteria, and may underestimate infiltrative disease, as observed in bones. The frequent presence of residual masses after treatment usually prevents classification of patients as complete response. Over time, positron emission tomography (PET) with F18-fluorodeoxyglucose (FDG) has become a prominent part of the workup at diagnosis and during follow-up. Recently, PET has been integrated in the revised response criteria for malignant lymphoma.
authors.affiliation: Service de Médecine Nucléaire, Hôpital Tenon, Paris.
authors.forename: F
authors.initials: F
authors.lastname: Montravers
authors.forename: C
authors.initials: C
authors.lastname: de Bazelaire
authors.forename: K
authors.initials: K
authors.lastname: Kerrou
authors.forename: C
authors.initials: C
authors.lastname: Farges
authors.forename: V
authors.initials: V
authors.lastname: Huchet
authors.forename: J-N
authors.initials: JN
authors.lastname: Talbot
authors.forename: J
authors.initials: J
authors.lastname: Frija
authors.forename: E
authors.initials: E
authors.lastname: de Kerviler
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging*; D008297:Male; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed